Seoul, South Korea

Young Joon Park

This inventor holds 7 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignees: Cj Healthcare Corporation, Alteogen, Inc., Imdpharm Inc.. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Young Joon Park. Retrieved from https://idiyas.com/inventor/young-joon-park-1a1ckx5g

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7 

% Patents Active = 85.7

 

 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2016-2026

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Young Joon Park: Innovator in Microsphere Technology and Human Growth Hormone Purification

Introduction

Young Joon Park is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the fields of microsphere technology and human growth hormone purification. With a total of six patents to his name, Park's work has the potential to impact various industries, particularly in pharmaceuticals and biotechnology.

Latest Patents

One of Park's latest patents is titled "Continuous process for preparing microspheres and microspheres prepared thereby." This invention describes a continuous method for creating microspheres by simultaneously injecting two emulsions, applying high pressure, and using an agitator. This innovative approach addresses the scale variables that have hindered traditional microsphere preparation methods, improving drug encapsulation efficiency and producing small, uniform particles.

Another notable patent is the "Method of purifying a long-acting human growth hormone." This invention focuses on a specific isoform of long-acting human growth hormone, known as NexP-hGH, which is produced by fusing human growth hormone with a highly glycosylated alpha-1 antitrypsin mutant. The purification method involves multiple chromatography steps, ensuring high purity and enhanced in vivo properties of the hormone.

Career Highlights

Throughout his career, Young Joon Park has worked with reputable companies such as CJ Healthcare Corporation and Alteogen, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical technology.

Collaborations

Park has collaborated with notable colleagues, including Myung Jin Shin and Hong Chul Jin. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their work.

Conclusion

Young Joon Park's contributions to microsphere technology and human growth hormone purification exemplify the impact of innovation in the medical field. His patents reflect a commitment to improving existing processes and developing new solutions that can benefit various industries.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…